3 completed, 1 terminated. 3 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Completed 3 |
| Phase 2 | 1 | Terminated 1 |
Follow DTRMWXHS-12: new trials by email Literature Review of DTRMWXHS-12 trials Research Report on DTRMWXHS-12
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study of a Triple Combination Therapy, DTRM-555, in Patients With R/R CLL or R/R Non-Hodgkin's Lymphomas DTRM-555 - Relapsed Chronic Lymphocytic Leukemia, Refractory Chronic Lymphocytic Leukemia | Phase 2 | Terminated | Zhejiang DTRM Biopharma | 55 | 2020-04-24 | 2025-01-08 |
| BTK Inhibitor DTRMWXHS-12 in Mantle Cell Lymphoma DTRMWXHS-12 - Mantle Cell Lymphoma | Phase 1 | Completed | Zhejiang DTRM Biopharma | 20 | 2019-01-11 | 2023-02-15 |
| Safety, Tolerability and PK of BTK Inhibitor DTRMWXHS-12 in Patients With B-Cell Lymphomas DTRMWXHS-12 - Chronic Lymphocytic Leukemia, B-cell Lymphomas | Phase 1 | Completed | Zhejiang DTRM Biopharma | 13 | 2016-09-01 | 2020-04-14 |
| Safety Study of BTK Inhibitor, DTRMWXHS-12, Used Singly or in Combination, in CLL and B-cell Lymphomas DTRMWXHS-12, DTRM-505, DTRM-555 - Chronic Lymphocytic Leukemia, B-Cell Lymphoma | Phase 1 | Completed | Zhejiang DTRM Biopharma | 48 | 2016-09-01 | 2020-11-27 |
Leukemia, Lymphocytic, Chronic, B-Cell (3) · Lymphoma, B-Cell (3) · Leukemia (1) · Leukemia, B-Cell (1) · Lymphatic Diseases (1) · Lymphoma (1) · Lymphoma, Follicular (1) · Lymphoma, Large B-Cell, Diffuse (1) · Lymphoma, Mantle-Cell (1) · Lymphoma, Non-Hodgkin (1) · Lymphoproliferative Disorders (1) · Neoplasms (1)
China (2) · United States (2)
Wei He, Ph.D. (3)